Zenotech Laboratories Ltd.

View in App
66.50 +0.45 ▲0.7%

01 December 2023, 11:13:00 AM
Volume: 5,473

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.zenotechlab.com
Market Cap 403.11 Cr.
Enterprise Value(EV) 403.11 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 1.53 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 43.22 Trailing Twelve Months Ending 2023-09
Industry PE 38.68 Trailing Twelve Months Ending 2023-09
Book Value / Share 14.19 Trailing Twelve Months Ending 2023-09
Price to Book Value 4.66 Calculated using Price: 66.05
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 6.10 Cr. 61,030,568 Shares
FaceValue 10
About Zenotech Laboratories Ltd.
Zenotech Laboratories Ltd, formerly known as Sunline Technologies Limited, was originally incorporated as Maa Shakti Tube Mill private Limited on June 15,1989. Zenotech develops and manufactures generic biopharmaceuticals and markets them to people with unmet medical needs around the world.

Zenotech Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Zenotech Laboratories Ltd. Performance

View details >>
1 Day
+0.68%
1 Week
-0.42%
1 Month
-1.95%
3 Month
+25.90%
6 Month
+27.96%
1 Year
-0.30%
2 Year
+52.70%
5 Year
+72.06%
10 Year
+162.74%

Zenotech Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -7.73 24.35 -2.48 37.26 15.15
Return on Capital Employed (%) -61.52 -65.68 -61.88 -5.95 18.32 0.48 15.26 18.39
Return on Assets (%) -45.43 -32.82 -38.33 -17.89 -3.76 12.67 -1.42 26.45 13.37

Zenotech Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds -27 -46 -66 42 39 50 48 71 82 87
Non Curr. Liab. 0 0 0 0 0 0 22 -4 -7 -6
Curr. Liab. 91 99 116 39 45 35 15 16 17 15
Minority Int.
Equity & Liab. 64 53 51 82 85 86 86 82 92 96
Non Curr. Assets 55 50 49 50 65 80 79 74 75 74
Curr. Assets 8 3 2 31 19 6 7 7 16 22
Misc. Exp. not W/O
Total Assets 64 53 51 82 85 86 86 82 92 96

Zenotech Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 4 2 2 11 13 26 22 37 42 41
Other Income 0 0 0 2 5 1 0 1 1 1
Total Income 4 2 2 14 18 27 23 37 44 41
Total Expenditure -24 -10 -13 -19 -17 -17 -16 -19 -22 -23
PBIDT -20 -8 -10 -6 1 10 7 18 22 19
Interest -7 -8 -8 -2 0 -1 -2 -1 0
Depreciation -4 -4 -4 -4 -4 -5 -6 -7 -7 -7
Taxation 12 -3 -2
Exceptional Items 2 6
PAT -30 -19 -20 -12 -3 11 -1 22 12 9
Adjusted EPS -8 -5 -5 -2 -1 2 0 4 2 2

Zenotech Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -24 -8 -5 2 -16 -14 11 6 18 21
Cash Fr. Inv. -1 0 6 -1 -3 -16 -21 -5 -2 -6
Cash Fr. Finan. 30 7 -1 -1 47 15 -3 0 -16 -6
Net Change 5 -1 0 0 28 -15 -12 1 0 9
Cash & Cash Eqvt 6 6 0 0 28 13 1 2 2 11

Zenotech Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 68.84 68.84 68.84 68.84 68.84 68.84 68.84 68.84 68.84
Public 31.16 31.16 31.16 31.16 31.16 31.16 31.16 31.16 31.16
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Zenotech Laboratories Ltd. Announcements

View details >>
Wed, 01 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Extract of Unaudited Financial Results for the quarter and half year ended September 30 2023
Mon, 30 Oct 2023
Outcome Of The Board Meeting For Consideration And Approval Of Financial Results For The Quarter And Half Year Ended September 30 2023
Unaduited Financial Results of the Company for the quarter and half year ended September 30
Mon, 30 Oct 2023
Unaudited Financial Results For The Quarter And Half Year Ended September 30 2023
Unaudited Financial Results for the quarter and half year ended September 30 2023

Zenotech Laboratories Ltd. Technical Scans

View details >>
Thu, 30 Nov 2023
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
High Increase in 2 Years High Increase in 2 Years
Closing Near 20 SMA Closing Near 20 SMA
CCI Trending Down CCI Trending Down

Zenotech Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 294,434.39 1,225.75 0.0%
Divi's Laboratories Ltd. 100,534.28 3,775.00 -0.4%
Cipla Ltd. 97,810.50 1,208.20 -0.3%
Dr. Reddy's Laboratories Ltd. 96,539.80 5,776.00 -0.2%
Apollo Hospitals Enterprise Ltd. 79,515.07 5,548.70 +0.4%
Mankind Pharma Ltd. 75,494.90 1,920.00 +1.2%
Torrent Pharmaceuticals Ltd. 71,999.19 2,130.40 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.44 1,225.75 0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 75.49 3,775.00 -0.4%
Cipla Ltd. Consolidated 2023-09 28.32 1,208.20 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.96 5,776.00 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.00 5,548.70 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 58.89 1,920.00 +1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 53.97 2,130.40 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.92 1,225.75 0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 7.93 3,775.00 -0.4%
Cipla Ltd. Consolidated 2023-09 3.94 1,208.20 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.79 5,776.00 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.23 5,548.70 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8.96 1,920.00 +1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.73 2,130.40 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,225.75 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,775.00 -0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,208.20 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,776.00 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,548.70 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,920.00 +1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,130.40 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,225.75 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,775.00 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,208.20 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,776.00 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,548.70 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,920.00 +1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,130.40 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,225.75 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,775.00 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,208.20 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,776.00 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,548.70 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,920.00 +1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,130.40 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,225.75 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,775.00 -0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,208.20 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,776.00 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,548.70 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,920.00 +1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,130.40 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,225.75 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,775.00 -0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,208.20 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,776.00 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,548.70 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,920.00 +1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,130.40 +0.2%

Zenotech Laboratories Ltd. FAQ's

What is Zenotech Laboratorie share price?
Can I buy Zenotech Laboratorie shares now?
What is the Market Cap of Zenotech Laboratorie?
What are the key metrics to analyse Zenotech Laboratorie?
What is the 52 Week High and Low of Zenotech Laboratorie?
What is the trend of Zenotech Laboratorie share price?